| Accession Number: | 0001209191-23-016702 |
| Date: | 2023-03-03 |
| Issuer: | VERA THERAPEUTICS, INC. (VERA) |
| Original Submission Date: |
SEIDENBERG BETH C
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120
BRISBANE, CA 94005
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| CLASS A COMMON STOCK | 2023-03-03 | P | 1,000 | a | $7.25 | 1,689,380 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the shares were purchased as follows: 967 shares by kleiner perkins caufield & byers xvi, llc ("kpcb xvi") and 33 shares by kpcb xvi founders fund, llc ("xvi founders"). all shares are held for convenience in the name of "kpcb holdings, inc., as nominee". the managing member of kpcb xvi and xvi founders is kpcb xvi associates, llc ("xvi associates"). l. john doerr, beth seidenberg, randy komisar, theodore e. schlein and wen hsieh, the managing members of xvi associates, exercise shared voting and dispositive control over the shares held by kpcb xvi and xvi founders. such managing members disclaim beneficial ownership of all shares held by kpcb xvi and xvi founders except to the extent of their pecuniary interest therein. |
| f2 | represents weighted average purchase price. the shares were purchased at prices ranging from $7.23 to $7.25. the reporting person will provide upon request, to the sec, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| f3 | consists of 1,633,464 shares of class a common stock held by kpcb xvi and 55,916 shares of class a common stock held by xvi founders. |
